644 related articles for article (PubMed ID: 17469849)
21. New developments in lantibiotic biosynthesis and mode of action.
Patton GC; van der Donk WA
Curr Opin Microbiol; 2005 Oct; 8(5):543-51. PubMed ID: 16118063
[TBL] [Abstract][Full Text] [Related]
22. Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.
Cruz JC; Iorio M; Monciardini P; Simone M; Brunati C; Gaspari E; Maffioli SI; Wellington E; Sosio M; Donadio S
J Nat Prod; 2015 Nov; 78(11):2642-7. PubMed ID: 26512731
[TBL] [Abstract][Full Text] [Related]
23. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
[TBL] [Abstract][Full Text] [Related]
24. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
25. Novel bacterial acetyl coenzyme A carboxylase inhibitors with antibiotic efficacy in vivo.
Freiberg C; Pohlmann J; Nell PG; Endermann R; Schuhmacher J; Newton B; Otteneder M; Lampe T; Häbich D; Ziegelbauer K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2707-12. PubMed ID: 16870762
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a novel antibacterial glycopeptide produced by Penicillium sp. M03.
Yang WH; Zhang WC; Lu XM; Jiang GS; Gao PJ
Lett Appl Microbiol; 2009 Apr; 48(4):393-7. PubMed ID: 19228293
[TBL] [Abstract][Full Text] [Related]
27. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
28. [Lantibiotics].
Israil A
Bacteriol Virusol Parazitol Epidemiol; 1992; 37(3-4):1-8. PubMed ID: 1340251
[TBL] [Abstract][Full Text] [Related]
29. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
Dischinger J; Josten M; Szekat C; Sahl HG; Bierbaum G
PLoS One; 2009 Aug; 4(8):e6788. PubMed ID: 19707558
[TBL] [Abstract][Full Text] [Related]
30. Mode of action of lipid II-targeting lantibiotics.
Bauer R; Dicks LM
Int J Food Microbiol; 2005 May; 101(2):201-16. PubMed ID: 15862882
[TBL] [Abstract][Full Text] [Related]
31. Cloning, sequencing and production of the lantibiotic mersacidin.
Bierbaum G; Brötz H; Koller KP; Sahl HG
FEMS Microbiol Lett; 1995 Mar; 127(1-2):121-6. PubMed ID: 7737474
[TBL] [Abstract][Full Text] [Related]
32. The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus.
Sass P; Jansen A; Szekat C; Sass V; Sahl HG; Bierbaum G
BMC Microbiol; 2008 Oct; 8():186. PubMed ID: 18947397
[TBL] [Abstract][Full Text] [Related]
33. Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis.
Mott JE; Shaw BA; Smith JF; Bonin PD; Romero DL; Marotti KR; Miller AA
J Antimicrob Chemother; 2008 Oct; 62(4):720-9. PubMed ID: 18567575
[TBL] [Abstract][Full Text] [Related]
34. The lantibiotic mersacidin is an autoinducing peptide.
Schmitz S; Hoffmann A; Szekat C; Rudd B; Bierbaum G
Appl Environ Microbiol; 2006 Nov; 72(11):7270-7. PubMed ID: 16980420
[TBL] [Abstract][Full Text] [Related]
35. Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?
Brötz H; Bierbaum G; Markus A; Molitor E; Sahl HG
Antimicrob Agents Chemother; 1995 Mar; 39(3):714-9. PubMed ID: 7793878
[TBL] [Abstract][Full Text] [Related]
36. Curvopeptin: a new lanthionine-containing class III lantibiotic and its co-substrate promiscuous synthetase.
Krawczyk B; Völler GH; Völler J; Ensle P; Süssmuth RD
Chembiochem; 2012 Sep; 13(14):2065-71. PubMed ID: 22907786
[TBL] [Abstract][Full Text] [Related]
37. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
38. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
40. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
